We are live on ! Find out more
RO

Robert Olstein Olstein Capital Management

AUM $458M
1-Year Est. Return 6.27%
 

Robert Olstein is the founder of Olstein Capital Management and a long-time advocate of forensic accounting and quality-of-earnings analysis in equity investing. His process looks beyond headline multiples to assess earnings sustainability and balance-sheet risk. Olstein’s work is frequently referenced by investors who prioritize accounting diligence.

This Fund
S&P 500
This Quarter Est. Return
+7.13%
1 Year Est. Return
+6.27%
3 Year Est. Return
+16.62%
5 Year Est. Return
+3.39%
10 Year Est. Return
+96.48%
AUM
$760M
AUM Growth
+$20M
Cap. Flow
-$28.2M
Cap. Flow %
-3.72%
Top 10 Hldgs %
21.1%
Holding
111
New
8
Increased
35
Reduced
53
Closed
5

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 22.37%
2 Industrials 19.98%
3 Financials 18.54%
4 Technology 15.14%
5 Healthcare 13.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UHS icon
76
Universal Health Services
UHS
$10.4B
$4.19M 0.55%
34,000
+10,000
+42% +$1.27M
MDT icon
77
Medtronic
MDT
$119B
$4.18M 0.55%
48,432
-17,568
-27% -$1.53M
CAT icon
78
Caterpillar
CAT
$381B
$4.17M 0.55%
+47,000
New +$3.85M
PEP icon
79
PepsiCo
PEP
$196B
$4.13M 0.54%
38,000
-8,000
-17% -$862K
CF icon
80
CF Industries
CF
$19.6B
$3.73M 0.49%
+153,000
New +$3.73M
SYK icon
81
Stryker
SYK
$126B
$3.73M 0.49%
32,000
-6,000
-16% -$699K
VSH icon
82
Vishay Intertechnology
VSH
$4.85B
$3.7M 0.49%
262,450
-36,015
-12% -$485K
DHR icon
83
Danaher
DHR
$154B
$3.68M 0.48%
+53,016
New +$3.76M
XYL icon
84
Xylem
XYL
$26.5B
$3.62M 0.48%
69,000
-2,000
-3% -$98.1K
JNJ icon
85
Johnson & Johnson
JNJ
$651B
$3.54M 0.47%
30,000
-11,000
-27% -$1.33M
TPR icon
86
Tapestry
TPR
$26B
$3.44M 0.45%
94,000
+32,000
+52% +$1.27M
ZTS icon
87
Zoetis
ZTS
$32.1B
$3.43M 0.45%
66,000
-16,000
-20% -$810K
SNA icon
88
Snap-on
SNA
$20.3B
$3.34M 0.44%
+22,000
New +$3.4M
PKG icon
89
Packaging Corp of America
PKG
$22.5B
$3.28M 0.43%
40,400
-63,600
-61% -$4.86M
PG icon
90
Procter & Gamble
PG
$336B
$3.23M 0.43%
36,000
-10,000
-22% -$869K
LCUT icon
91
Lifetime Brands
LCUT
$211M
$2.86M 0.38%
212,698
-7,402
-3% -$102K
HLIT icon
92
Harmonic Inc
HLIT
$1.36B
$2.68M 0.35%
452,100
-400,200
-47% -$1.6M
NOVT icon
93
Novanta
NOVT
$5.49B
$2.53M 0.33%
146,055
-41,425
-22% -$682K
FTD
94
DELISTED
FTD Companies, Inc. Common Stock
FTD
$2.48M 0.33%
120,579
+28,679
+31% +$688K
FDX icon
95
FedEx
FDX
$76.9B
$2.45M 0.32%
14,000
TOWN icon
96
Towne Bank
TOWN
$3.49B
$2.4M 0.32%
100,025
+75
+0.1% +$1.74K
MLR icon
97
Miller Industries
MLR
$649M
$2.38M 0.31%
104,575
+305
+0.3% +$6.6K
ATRO icon
98
Astronics
ATRO
$3.35B
$2.31M 0.3%
81,508
-28,027
-26% -$717K
NTUS
99
DELISTED
Natus Medical Inc
NTUS
$2.19M 0.29%
55,850
-1,175
-2% -$46.9K
BHI
100
DELISTED
Baker Hughes
BHI
$2.07M 0.27%
41,000

Similar funds

Robert Olstein's Q3 2016 Portfolio in Review

As of Q3 2016, Robert Olstein held 111 positions worth $760M, up 2.7% from $740M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Robert Olstein withdrew a net $28.2M in Q3 2016, closing 5 positions and reducing 53 holdings. Its most notable exit was Pentair, an estimated $6.12M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, down from 24% a quarter earlier, followed by Industrials and Financials.

Against the trend, Robert Olstein opened a new position in Stericycle Inc worth $6.89M.

  • Robert Olstein's largest Q3 2016 buy was Stericycle Inc: 86,000 shares worth $6.89M.
  • Robert Olstein added most to Twenty-First Century Fox, Inc. Class B in Q3 2016, an estimated $2.84M increase.
  • Robert Olstein's biggest Q3 2016 reduction was WestRock Company, cutting an estimated $5.37M.
  • Robert Olstein fully exited Pentair in Q3 2016, selling an estimated $6.12M.
  • Robert Olstein's ten largest holdings make up 21% of its $760M portfolio in Q3 2016.
  • Robert Olstein opened 8 new positions and closed 5 in Q3 2016.
  • Robert Olstein's portfolio value rose 2.7% quarter-over-quarter to $760M.

Based on Olstein Capital Management's 13F filing for Q3 2016, filed 4 Nov 2016.